MDS Virtual Congress 2021 Archives - Page 102 of 132

WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Baseline Analyses

J. Adams, E. Dorsey, T. Ruiz Herrero, P. Auinger, R. Alexander, R. Rubens, B. Tracey, N. Zach, P. O'Donnell, A. Best, J. Severson, M. Kostrzebski, E. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Fisher, J. Edgerton, T. Kangarloo (Rochester, USA)
Wearable Devices in Movement Disorder Trials to Provide Objective Measures

C. Martino, A. Lledó, J. Hamlet, S. Mendick (Wilmington, USA)
Wearable sensor motor outcomes across patients with Parkinson’s disease from Asian, Black, and Caucasian ethnicity in the United Kingdom

D. van Wamelen, L. Batzu, A. Podlewska, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)
Wearable Sensor-Driven Responsive Deep Brain Stimulation for Essential Tremor

S. Cernera, J. Alcantara, E. Opri, J. Cagle, R. Eisinger, Z. Boogaart, L. Pramanik, M. Kelberman, B. Patel, K. Foote, M. Okun, A. Gunduz (Gainesville, USA)
Wearable sensors are able to identify individuals in the prodromal phase of X-linked Dystonia-Parkinsonism

J. Steinhardt, H. Hanssen, M. Heldmann, A. Sprenger, A. Domingo, A. Domingo, C. Reyes, R. Rosales, C. Klein, T. Muente, A. Westenberger, J. Oropilla, C. Siesta, N. Brueggemann (Luebeck, Germany)
What do medical students know about dystonia? Results before and after a brief educational intervention.

S. Khan, N. Sowemimo, J. Alty, J. Cosgrove (Leeds, United Kingdom)
What predicts RBD in PD patients: video-polysomnographycally supported data from advanced, fluctuating Parkinson’s disease?

ML. Muntean, F. Sixel-Döring, D. Peterson, A. Leha, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)
White matter and cognition in Parkinson’s disease

S. Ryman, C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson (Albuquerque, USA)
Whole genome sequencing aids in diagnosing GCH1 dopa responsive dystonia in two Peruvian patients and influences medical management

L. Urbina-Ramirez, J. La Serna-Infantes, E. Sarapura-Castro, A. Rivera-Valdivia, E. Thorpe, D. Perry, K. Milla-Neyra, C. Galarreta, M. Dueñas-Roque, M. Cornejo-Olivas (Lima, Peru)
Whole-Exome Sequencing in a Movement Disorders Clinic

C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)
Whole-transcriptome analysis of monocyte-derived macrophages from patients with Parkinson’s disease associated with mutations in the GBA gene

T. Usenko, A. Panteleeva, K. Basharova, M. Nikolaev, A. Kopytova, A. Bezrukova, K. Senkevich, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)
Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.

A. Delva, L. Michiels, M. Koole, K. van Laere, W. Vandenberghe (Leuven, Belgium)